Yong King W, Soule Steven, Hunt Penny
RMO Unit, Christchurch Hospital, Private Bag 4710, Christchurch, New Zealand.
N Z Med J. 2014 May 23;127(1394):85-7.
The diagnosis of Hashimoto's encephalopathy is made when no other cause is found for an acute encephalopathic illness, in the presence of positive thyroid autoantibodies, and is supported by a response to steroid therapy. A 59-year-woman developed an encephalopathic illness with mixed aphasia, global weakness and generalised seizures requiring intubation and ICU admission. Extensive imaging and laboratory investigations looking for an underlying cause for the encephalopathy were unremarkable. Thyroid autoantibodies were strongly positive, raising the possibility of Hashimoto's encephalopathy. Thyroid function testing showed profound primary hypothyroidism. The patient was commenced on high-dose methyprednisolone, with prompt cessation of seizure activity. Thyroxine replacement was commenced, with the methyprednisolone switched to oral prednisone and slowly weaned. The patient had no further seizures and ultimately made a full recovery.
当在急性脑病性疾病找不到其他病因、存在甲状腺自身抗体阳性且对类固醇治疗有反应时,即可诊断为桥本脑病。一名59岁女性患脑病性疾病,伴有混合性失语、全身无力和全身性癫痫发作,需要插管并入住重症监护病房。为寻找脑病的潜在病因进行了广泛的影像学和实验室检查,结果均无异常。甲状腺自身抗体呈强阳性,增加了桥本脑病的可能性。甲状腺功能测试显示严重的原发性甲状腺功能减退。患者开始使用大剂量甲泼尼龙治疗,癫痫活动迅速停止。开始进行甲状腺素替代治疗,将甲泼尼龙换为口服泼尼松并逐渐减量。患者未再发生癫痫发作,最终完全康复。